Targeted Oncology13 小时
Selection of Next-Gen BTK in CLL Limited By Lack of Direct Comparison
During a Case-Based Roundtable® event, Nakhle Saba, MD, and participants discussed the data supporting the 2 newer BTK ...
Targeted Oncology22 小时
Balstilimab Plus Botensilimab Shows Better Response in MSS mCRC
Marwan G. Fakih, MD, discussed the implications of the findings from the phase 2 study for patients with microsatellite ...
Targeted Oncology16 小时
LaCasce on Bispecific Antibodies Transforming Lymphoma Care
Ann LaCasce, MD, MMSc, director of the Dana-Farber/Massachusetts General Brigham Fellowship in Hematology/Oncology, highlights the role of bispecific antibodies in lymphoma research.